Since company is an artificially created judicial person, its affairs are administered by the company's board of directors. These people convene meets at regular periods and take decision on important matters such as issuance of dividend, bonus issue etc. As per Uday Kotak Committee's recommendations, all listed companies need to mandatorily hold board meetings at least once every three months and there needs to be at least 4 board meets each year.
Furthermore, the decisions taken at the board meet are of immense value and impacts short-term investors more when compared to long-term investors.
So, here are 3 board meets due to be held over the course of this month for various agendas.
1. Medico Remedies:
The company is a pharmaceutical formulation manufacturing entity with manufacturing and marketing capabilities in formulation and focus chiefly on anti-infective, Beta-Lactums.
The company in an exchange filing on September 30,2021 announced that its board will consider bonus issue. Medico Remedies informed BSE that the meeting of the Board of Directors of the Company is scheduled to be held on October 07, 2021 to recommend and approve issue of Bonus shares to the equity shareholders of the Company. Other than that the company will also transact some of the other dealings such as consider increase in the authorized share capital, approval for the proposal of Migration of Company from SME platform of BSE to Main Board of BSE Limited as well as on the Main Board of NSE Limited etc.
Medico Remedies second quarter earnings are also expected on October 7, 2021. The company's 52-week high price hit today is Rs. 312.3 per share.
2. Earum Pharmaceuticals
The company incorporated in the year 2012 is a Small Cap scrip with a market capitalization of Rs. 135 crore. The company into the pharma business is involved in marketing, trading and distribution of wide range of pharmaceutical formulation products such as anti-biotic drugs, anti-malarial drugs, anti-allergic & anti cold drugs, analgesic/ anti-pyretic & anti inflammatory drugs, dermatology products, cerebral activator drugs, neurological drugs, gastro intestinal drugs, steroids, gynecology drugs, calcium, multivitamins, anti-oxidants and injections. Other than this, the company also deals in the trading of APIs or active pharmaceutical ingredients.
The company via BSE filing dated September 23, 2021 informed that the board meet is scheduled for October 8 to consider proposal of split/ sub-division of Equity Shares of the Company.
Note: A stock split is a corporate action in which a company divides its existing shares into multiple shares to boost the liquidity of the shares.
Tata Consultancy Services, the global leader in IT and consulting services offers a range of services from cloud, analytics and insights, blockchain to cyber security and quality engineering among others.
The company's board meet is scheduled for October 8, 2021 wherein the main agenda remains announcement of second quarter earnings and second interim dividend for the FY22.Earlier the tech company declared an interim dividend of Rs. 7 per share for which the stock turned ex-dividend on July 15, 2021.